Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-12 Sale |
2024-08-14 4:57 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
29,881 | $56.53 | $1,689,294 | 69,874 (Direct) |
View |
| 2024-07-23 Sale |
2024-07-24 5:48 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $55 | $1,100,023 | 221,752 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-23 4:37 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $53.93 | $269,662 | 15,480 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-28 4:06 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $51.93 | $1,557,940 | 60,480 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:17 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $49.43 | $494,260 | 179,891 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 4:15 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
20,000 | $50.31 | $1,006,300 | 99,755 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 5:24 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $45.27 | $905,480 | 221,606 (Direct) |
View |
| 2024-04-16 Sale |
2024-04-17 7:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $38.42 | $768,390 | 261,606 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 5:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $41.95 | $839,100 | 244,484 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-28 6:49 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $39.75 | $794,923 | 224,714 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $36 | $720,000 | 211,681 (Direct) |
View |
| 2023-12-12 Sale |
2023-12-13 7:48 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $40.01 | $800,262 | 251,681 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:18 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $39.43 | $788,670 | 179,269 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-17 7:28 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $36.52 | $365,200 | 193,010 (Direct) |
View |
| 2023-09-19 Sale |
2023-09-19 4:09 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $39.1 | $390,980 | 203,010 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-23 Exercise |
2024-07-24 5:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,715 | $8.11 | 221,752 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-24 5:48 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 221,752 (Direct) |
View |
| 2024-07-24 Exercise |
2024-07-24 5:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,285 | $16.65 | 221,752 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $22.5 | 15,480 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $0 | 15,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $22.5 | 60,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $0 | 60,480 (Direct) |
View |
| 2024-06-18 Exercise |
2024-06-20 4:17 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $8.11 | 179,891 (Direct) |
View |
| 2024-06-18 Exercise |
2024-06-20 4:17 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 179,891 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:17 pm |
2025-06-12 N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
20,137 | $0 | 20,137 (Direct) |
View |
| 2024-05-21 Exercise |
2024-05-22 5:24 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $8.11 | 221,606 (Direct) |
View |
| 2024-05-21 Exercise |
2024-05-22 5:24 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 221,606 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:11 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
15,305 | $0 | 128,559 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:08 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director |
15,305 | $0 | 29,576 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:05 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
15,305 | $0 | 202,309 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:01 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Krishnan Mahesh Director |
15,305 | $0 | 15,305 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:56 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
15,305 | $0 | 62,415 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:54 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
15,305 | $0 | 24,558 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:51 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
15,305 | $0 | 55,591 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-17 7:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $8.11 | 261,606 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-17 7:22 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 261,606 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,890 | $8.11 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,618 | $0 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
292 | $16.78 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,436 | $12.07 | 229,891 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-13 5:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
3,551 | $8.11 | 244,484 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-13 5:22 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 244,484 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-13 5:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
16,449 | $12.07 | 244,484 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-28 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
7,471 | $8.11 | 224,714 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-28 6:49 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
7,471 | $0 | 224,714 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:12 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
38,659 | $0 | 38,659 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:08 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
57,109 | $0 | 57,109 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:05 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
54,473 | $0 | 54,473 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:01 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
182,746 | $0 | 182,746 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:59 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,257 | $36.1 | 194,100 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:59 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,376 | $0 | 194,100 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:55 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
2,577 | $36.1 | 26,068 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:55 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
4,796 | $0 | 26,068 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,601 | $36.1 | 41,653 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
10,422 | $0 | 41,653 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
20,362 | $36.1 | 769,386 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
37,884 | $0 | 769,386 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
3,386 | $0 | 167,354 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,040 | $35.91 | 167,354 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,479 | $0 | 167,354 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,254 | $0 | 11,913 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
686 | $35.91 | 11,913 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
13,092 | $0 | 672,314 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
24,655 | $35.91 | 672,314 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
32,781 | $0 | 672,314 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,133 | $0 | 157,143 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,901 | $35.49 | 157,143 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,502 | $0 | 10,091 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,477 | $35.49 | 10,091 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
31,281 | $0 | 638,004 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
16,943 | $35.49 | 638,004 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:07 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 211,681 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $12.07 | 211,681 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-05 4:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
2,957 | $35.78 | 24,683 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 4:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
7,611 | $0 | 24,683 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A 2025-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 251,681 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,533 | $13.81 | 251,681 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,467 | $12.07 | 251,681 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A 2025-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 179,269 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
18,292 | $13.81 | 179,269 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
1,708 | $16.78 | 179,269 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-17 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $19.98 | 193,010 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-17 7:28 pm |
N/A 2030-02-10 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 193,010 (Direct) |
View |
| 2023-09-19 Exercise |
2023-09-19 4:09 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $19.98 | 203,010 (Direct) |
View |
| 2023-09-19 Exercise |
2023-09-19 4:09 pm |
N/A 2030-02-10 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 203,010 (Direct) |
View |